Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 89 Records) |
Query Trace: CES1[original query] |
---|
Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report. Medicine 2020 9 99 (36): e22084. Wu Tingting, Xia Xiaotong, Fu Jinglan, Chen Wenjun, Zhang Jinh |
Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran. Advances in therapy 2020 6 37 (8): 3537-3550. Zubiaur Pablo, Saiz-Rodríguez Miriam, Ochoa Dolores, Navares-Gómez Marcos, Mejía Gina, Román Manuel, Koller Dora, Soria-Chacartegui Paula, Almenara Susana, Abad-Santos Francis |
The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation. British journal of clinical pharmacology 2020 Nov . Ji Qiuyi, Zhang Chunyu, Xu Qing, Wang Zi, Li Xiaoye, Lv Qianzh |
Copy number variation in the CES1 gene and the risk of non-alcoholic fatty liver in a Chinese Han population. Scientific reports 2021 7 11 (1): 13984. Chen Bing Bing, Yan Jian Hui, Zheng Jing, Peng He Wei, Cai Xiao Ling, Pan Xin Ting, Li Hui Quan, Hong Qi Zhu, Peng Xian |
Human Variability in Carboxylesterases and carboxylesterase-related Uncertainty Factors for Chemical Risk Assessment. Toxicology letters 2021 7 350 162-170. Di Consiglio E, Darney K, Buratti F M, Turco L, Vichi S, Testai E, Lautz L S, Dorne J L C |
Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects. British journal of clinical pharmacology 2021 5 87 (12): 4691-4700. Her Lucy H, Wang Xinwen, Shi Jian, Choi Hee Jae, Jung Sun Min, Smith Logan S, Wu Audrey H, Bleske Barry E, Zhu Hao-J |
The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects. Pharmacogenomics and personalized medicine 2021 5 14 477-485. Liu Yue, Yang Chenguang, Qi Wenyuan, Pei Zuowei, Xue Wei, Zhu Huolan, Dong Min, Guo Ying, Cong Duanduan, Wang Fa |
Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users. Clinical pharmacology and therapeutics 2021 May . Lähteenmäki Jaakko, Vuorinen Anna-Leena, Pajula Juha, Harno Kari, Lehto Mika, Niemi Mikko, van Gils Ma |
Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers. Clinical and translational science 2021 Mar . Wang Xinwen, Her Lucy, Xiao Jingcheng, Shi Jian, Wu Audrey H, Bleske Barry E, Zhu Hao-J |
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine. Cancer chemotherapy and pharmacology 2021 Feb . Liu Duo, Li Xuehua, Li Xiang, Wang Huiqi, Dong M |
Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in pharmacology 2021 2 11 593982. Xu Ru-Jun, Kong Wei-Min, An Xiao-Fei, Zou Jian-Jun, Liu Li, Liu Xiao-Do |
Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach. Frontiers in pharmacology 2021 1 11 591854. Liu Shuaibing, Wang Ziteng, Tian Xin, Cai Weim |
Associations among plasma concentrations of edoxaban and M-4, prothrombin time, and the SLCO1B1*15 haplotype in patients with non-valvular atrial fibrillation. Therapeutic drug monitoring 2022 Sep . Nakagawa Junichi, Kinjo Takahiko, Aiuchi Naoya, Ueno Kayo, Tomita Hirofumi, Niioka Takeno |
Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis. Frontiers in cardiovascular medicine 2022 8 9 959916. Li Haobo, Zhang Zhu, Weng Haoyi, Qiu Yuting, Zubiaur Pablo, Zhang Yu, Fan Guohui, Yang Peiran, Vuorinen Anna-Leena, Zuo Xianbo, Zhai Zhenguo, Wang Ch |
In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir. Chemico-biological interactions 2022 8 365 110097. Zhang Qingchen, Melchert Philip W, Markowitz John |
SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population. Frontiers in genetics 2022 6 13 873031. Xie Qiufen, Li Yuan, Liu Zhiyan, Mu Guangyan, Zhang Hanxu, Zhou Shuang, Wang Zhe, Wang Zining, Jiang Jie, Li Xin, Xiang Qian, Cui Yim |
Physiologically-Based Pharmacokinetic Modeling to Predict Methylphenidate Exposure Affected by Interplay Among Carboxylesterase 1 Pharmacogenetics, Drug-Drug Interactions, and Sex. Journal of pharmaceutical sciences 2022 May . Xiao Jingcheng, Shi Jian, Thompson Brian R, Smith David E, Zhang Tao, Zhu Hao-J |
The Influence of the CES1 Genotype on the Pharmacokinetics of Enalapril in Patients with Arterial Hypertension. Journal of personalized medicine 2022 4 12 (4): . Ikonnikova Anna, Rodina Tatiana, Dmitriev Artem, Melnikov Evgeniy, Kazakov Ruslan, Nasedkina Tatia |
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver 2022 2 42 (4): 796-808. Loucks Catrina M, Lin Jennifer J, Trueman Jessica N, Drögemöller Britt I, Wright Galen E B, Chang Wan-Chun, Li Kathy H, Yoshida Eric M, Ford Jo-Ann, Lee Samuel S, Crotty Pam, Kim Richard B, Al-Judaibi Bandar, Schwarz Ute I, Ramji Alnoor, Farivar Jeanette F, Tam Edward, Walston Lori Lee, Ross Colin J D, Carleton Bruce |
CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmacogenomics and personalized medicine 2022 11 15 951-957. Hernandez Marta H, Bote Valentin, Serra-LLovich Alexandre, Cendros Marc, Salazar Juliana, Mestres Conxita, Guijarro Silvina, Alvarez Aida, Lamborena Cristina, Mendez Iria, Sanchez Bernardo, Hervas Amaia, Arranz Maria |
The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation. BMC cardiovascular disorders 2022 11 22 (1): 481. Zhu Zhu, Qian Chenyue, Su Cunjing, Tao Hong, Mao Jiaojiao, Guo Zhening, Zhu Xinyi, Pan J |
Effect of Genotype on the Pharmacokinetics and Bleeding Events of Direct Oral Anticoagulants: A Systematic Review and Meta-analysis. Journal of clinical pharmacology 2022 10 63 (3): 277-287. Shi Jinying, Wu Tingting, Wu Shuyi, Chen Xiaochun, Ye Qin, Zhang Jinh |
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC. Genes 2023 6 14 (6): . Ayan Abdrakhmanov, Ainur Akilzhanova, Aizhan Shaimerdinova, Madina Zhalbinova, Gulnara Tuyakova, Svetlana Abildinova, Rustam Albayev, Bayan Ainabekova, Assel Chinybayeva, Zhanasyl Suleimen, Makhabbat Bekbossyno |
Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure. European journal of clinical pharmacology 2023 3 . Luo Hong-Yu, Gao Li-Chen, Long Hui-Zhi, Zhou Zi-Wei, Xu Shuo-Guo, Li Feng-Jiao, Li Hong-Li, Cheng Yan, Li Cai-Xia, Peng Xing-Yu, Li Liang, Chen Ran, Deng Pi |
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients. Pharmaceutics 2023 11 15 (11): . Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral |
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series. Journal of clinical psychopharmacology 2023 10 . Andrie C Westerkamp, Rob Rodrigues Pereira, Vera R Huitema, Ester A M Kouwert, Maja Matic, Ron H N van Schaik, Nieko Punt, Robert A Schoevers, Daan J To |
Genome-Wide Association Screening Determines Peripheral Players in Male Fertility Maintenance. International journal of molecular sciences 2023 1 24 (1): . Greither Thomas, Behre Hermann M, Herlyn Holg |
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 1 159 114232. de With Mirjam, van Doorn Leni, Maasland Demi C, Mulder Tessa A M, Oomen-de Hoop Esther, Mostert Bianca, Homs Marjolein Y V, El Bouazzaoui Samira, Mathijssen Ron H J, van Schaik Ron H N, Bins Sand |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: